ATENOLOL

ATENOLOL was reported 133248 times

These side effects are most commonly reported by patients taking ATENOLOL:

# Side effect Count
0 DRUG INEFFECTIVE 8061
1 NAUSEA 7924
2 FATIGUE 7694
3 DIARRHOEA 7124
4 DYSPNOEA 6387
5 DIZZINESS 6333
6 HEADACHE 5989
7 PAIN 5767
8 ASTHENIA 5012
9 FALL 4728
10 ARTHRALGIA 4669
11 MALAISE 4305
12 VOMITING 4232
13 HYPERTENSION 4111
14 OFF LABEL USE 4092
15 PAIN IN EXTREMITY 3782
16 HYPOTENSION 3755
17 WEIGHT DECREASED 3481
18 RASH 3311
19 ANXIETY 3142
20 PRURITUS 3134
21 PNEUMONIA 3130
22 COUGH 3089
23 CHEST PAIN 3036
24 BLOOD PRESSURE INCREASED 3035
25 INSOMNIA 3009
26 DEATH 2936
27 BACK PAIN 2902
28 DRUG INTERACTION 2776
29 DEPRESSION 2719
30 RENAL FAILURE 2703
31 MYOCARDIAL INFARCTION 2698
32 PYREXIA 2600
33 ACUTE KIDNEY INJURY 2581
34 ABDOMINAL PAIN 2539
35 FEELING ABNORMAL 2487
36 ANAEMIA 2463
37 DECREASED APPETITE 2414
38 CONFUSIONAL STATE 2378
39 CONSTIPATION 2369
40 OEDEMA PERIPHERAL 2343
41 CONDITION AGGRAVATED 2339
42 MYALGIA 2338
43 GAIT DISTURBANCE 2327
44 CEREBROVASCULAR ACCIDENT 2258
45 ABDOMINAL PAIN UPPER 2241
46 BRADYCARDIA 2234
47 URINARY TRACT INFECTION 2217
48 ATRIAL FIBRILLATION 2167
49 MUSCLE SPASMS 2157
50 WEIGHT INCREASED 2145
51 SOMNOLENCE 2115
52 DEHYDRATION 2028
53 BLOOD GLUCOSE INCREASED 2018
54 ALOPECIA 1980
55 CHRONIC KIDNEY DISEASE 1952
56 SYNCOPE 1898
57 PARAESTHESIA 1856
58 HYPERHIDROSIS 1775
59 TREMOR 1769
60 CARDIAC FAILURE CONGESTIVE 1743
61 PERIPHERAL SWELLING 1740
62 ERYTHEMA 1710
63 PALPITATIONS 1697
64 HYPOAESTHESIA 1676
65 JOINT SWELLING 1660
66 ABDOMINAL DISCOMFORT 1636
67 DRUG HYPERSENSITIVITY 1624
68 MUSCULAR WEAKNESS 1558
69 LOSS OF CONSCIOUSNESS 1557
70 DIABETES MELLITUS 1542
71 VISION BLURRED 1525
72 COMPLETED SUICIDE 1497
73 RENAL FAILURE ACUTE 1470
74 HYPERSENSITIVITY 1451
75 HAEMOGLOBIN DECREASED 1446
76 TOXICITY TO VARIOUS AGENTS 1441
77 FLUSHING 1426
78 INJECTION SITE PAIN 1408
79 GASTROOESOPHAGEAL REFLUX DISEASE 1357
80 DYSPEPSIA 1343
81 DRUG DOSE OMISSION 1267
82 MEMORY IMPAIRMENT 1256
83 DRY MOUTH 1250
84 URTICARIA 1249
85 CONTUSION 1248
86 HYPONATRAEMIA 1245
87 NASOPHARYNGITIS 1229
88 OVERDOSE 1222
89 HEART RATE INCREASED 1213
90 BLOOD CREATININE INCREASED 1200
91 CHEST DISCOMFORT 1193
92 BALANCE DISORDER 1182
93 RHEUMATOID ARTHRITIS 1152
94 ARTHRITIS 1151
95 RENAL IMPAIRMENT 1142
96 CHILLS 1138
97 PRODUCT USE ISSUE 1136
98 GASTROINTESTINAL HAEMORRHAGE 1130
99 DYSPHAGIA 1120
100 INCORRECT DOSE ADMINISTERED 1098
101 ABDOMINAL DISTENSION 1086
102 NEUROPATHY PERIPHERAL 1082
103 EPISTAXIS 1068
104 CORONARY ARTERY DISEASE 1053
105 BLOOD PRESSURE DECREASED 1045
106 MUSCULOSKELETAL STIFFNESS 1044
107 CARDIAC ARREST 1040
108 SINUSITIS 1020
109 CARDIAC DISORDER 1016
110 BLOOD CHOLESTEROL INCREASED 1006
111 SEPSIS 996
112 THROMBOCYTOPENIA 995
113 PLATELET COUNT DECREASED 988
114 INFECTION 977
115 PULMONARY EMBOLISM 977
116 CATARACT 956
117 TACHYCARDIA 950
118 BRONCHITIS 940
119 HEART RATE DECREASED 940
120 DYSGEUSIA 914
121 INFLUENZA 911
122 PRODUCT USE IN UNAPPROVED INDICATION 896
123 OSTEOARTHRITIS 895
124 PRODUCT QUALITY ISSUE 892
125 HYPOKALAEMIA 891
126 PSORIASIS 889
127 MUSCULOSKELETAL PAIN 887
128 OROPHARYNGEAL PAIN 884
129 VISUAL IMPAIRMENT 882
130 SWELLING 880
131 DRUG INTOLERANCE 879
132 HYPERKALAEMIA 875
133 CARDIAC FAILURE 858
134 HAEMORRHAGE 857
135 EMOTIONAL DISTRESS 844
136 ARTHROPATHY 841
137 PLEURAL EFFUSION 840
138 PRODUCT DOSE OMISSION ISSUE 840
139 HOT FLUSH 838
140 INJURY 826
141 ALANINE AMINOTRANSFERASE INCREASED 816
142 WHITE BLOOD CELL COUNT DECREASED 812
143 BURNING SENSATION 811
144 GENERAL PHYSICAL HEALTH DETERIORATION 800
145 DYSPHONIA 795
146 RHABDOMYOLYSIS 792
147 ARRHYTHMIA 790
148 HYPOGLYCAEMIA 785
149 STRESS 782
150 LETHARGY 778
151 SWELLING FACE 775
152 COVID-19 772
153 AMNESIA 764
154 RESPIRATORY FAILURE 759
155 HALLUCINATION 750
156 FEELING HOT 745
157 FLATULENCE 745
158 MIGRAINE 745
159 HEPATIC ENZYME INCREASED 736
160 VERTIGO 734
161 NECK PAIN 730
162 ANGINA PECTORIS 729
163 NERVOUSNESS 729
164 NEUTROPENIA 728
165 PULMONARY OEDEMA 728
166 THROMBOSIS 728
167 UNEVALUABLE EVENT 721
168 RECTAL HAEMORRHAGE 715
169 TRANSIENT ISCHAEMIC ATTACK 711
170 OEDEMA 708
171 DEEP VEIN THROMBOSIS 706
172 ASPARTATE AMINOTRANSFERASE INCREASED 702
173 MOBILITY DECREASED 702
174 ACUTE MYOCARDIAL INFARCTION 699
175 DRY SKIN 697
176 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 687
177 GASTROINTESTINAL DISORDER 682
178 INTERNATIONAL NORMALISED RATIO INCREASED 681
179 DISEASE PROGRESSION 677
180 RHINORRHOEA 676
181 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 675
182 HYPERGLYCAEMIA 671
183 TYPE 2 DIABETES MELLITUS 667
184 RENAL INJURY 664
185 CELLULITIS 661
186 AGITATION 660
187 RASH PRURITIC 651
188 PANCREATITIS 650
189 C-REACTIVE PROTEIN INCREASED 637
190 ASTHMA 622
191 INFUSION RELATED REACTION 621
192 OSTEOPOROSIS 617
193 CONVULSION 614
194 OXYGEN SATURATION DECREASED 611
195 BONE PAIN 603
196 SLEEP DISORDER 601
197 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 600
198 TINNITUS 600
199 INJECTION SITE ERYTHEMA 594
200 INFLUENZA LIKE ILLNESS 590
201 SUICIDAL IDEATION 586
202 THROAT IRRITATION 581
203 BLOOD GLUCOSE DECREASED 577
204 INTENTIONAL PRODUCT MISUSE 571
205 SPEECH DISORDER 571
206 NEPHROLITHIASIS 567
207 POLLAKIURIA 566
208 BLOOD PRESSURE SYSTOLIC INCREASED 560
209 SKIN EXFOLIATION 560
210 EYE PAIN 559
211 METABOLIC ACIDOSIS 554
212 DEPRESSED LEVEL OF CONSCIOUSNESS 552
213 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 550
214 WHITE BLOOD CELL COUNT INCREASED 549
215 DYSPNOEA EXERTIONAL 548
216 BLISTER 543
217 NASAL CONGESTION 543
218 DYSURIA 542
219 BLOOD PRESSURE FLUCTUATION 541
220 HAEMATOCHEZIA 540
221 DEPRESSED MOOD 539
222 PANCYTOPENIA 537
223 BLOOD POTASSIUM DECREASED 536
224 STOMATITIS 532
225 CARDIO-RESPIRATORY ARREST 530
226 MEDICATION ERROR 530
227 END STAGE RENAL DISEASE 526
228 LACTIC ACIDOSIS 522
229 HAEMATOCRIT DECREASED 520
230 WHEEZING 520
231 SINUS BRADYCARDIA 518
232 CHOLELITHIASIS 515
233 HERPES ZOSTER 511
234 RED BLOOD CELL COUNT DECREASED 506
235 ADVERSE EVENT 505
236 DISORIENTATION 504
237 URINARY INCONTINENCE 504
238 MALIGNANT NEOPLASM PROGRESSION 503
239 THERAPEUTIC RESPONSE DECREASED 502
240 SUICIDE ATTEMPT 498
241 DRUG EFFECT DECREASED 496
242 HEART RATE IRREGULAR 496
243 INFLAMMATION 496
244 PRODUCT SUBSTITUTION ISSUE 492
245 CORONARY ARTERY OCCLUSION 489
246 SKIN DISCOLOURATION 489
247 SEIZURE 485
248 BLOOD UREA INCREASED 481
249 DYSARTHRIA 480
250 INTENTIONAL OVERDOSE 475
251 BLOOD CREATINE PHOSPHOKINASE INCREASED 472
252 RENAL DISORDER 471
253 FLUID RETENTION 467
254 TREATMENT NONCOMPLIANCE 467
255 COMA 464
256 HAEMATURIA 463
257 HOSPITALISATION 462
258 LIVER DISORDER 459
259 PRODUCTIVE COUGH 457
260 DRY EYE 454
261 INTENTIONAL PRODUCT USE ISSUE 453
262 SEPTIC SHOCK 451
263 LIMB DISCOMFORT 449
264 SWOLLEN TONGUE 448
265 INJECTION SITE HAEMORRHAGE 446
266 GASTRITIS 445
267 INTERSTITIAL LUNG DISEASE 444
268 ANGIOEDEMA 438
269 IRRITABILITY 438
270 FEAR 437
271 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 434
272 SHOCK 434
273 SKIN ULCER 434
274 UPPER RESPIRATORY TRACT INFECTION 433
275 ANHEDONIA 431
276 ILLNESS 431
277 DISTURBANCE IN ATTENTION 430
278 LIVER FUNCTION TEST ABNORMAL 430
279 ORTHOSTATIC HYPOTENSION 429
280 HEAD INJURY 427
281 WRONG TECHNIQUE IN DRUG USAGE PROCESS 420
282 HEPATIC STEATOSIS 417
283 ADVERSE DRUG REACTION 416
284 BLOOD TRIGLYCERIDES INCREASED 416
285 HYPOTHYROIDISM 415
286 EYE IRRITATION 414
287 IMPAIRED HEALING 414
288 HYPOXIA 411
289 MELAENA 411
290 BLOOD ALKALINE PHOSPHATASE INCREASED 410
291 PRESYNCOPE 406
292 FEMUR FRACTURE 404
293 COGNITIVE DISORDER 403
294 ROAD TRAFFIC ACCIDENT 403
295 SYNOVITIS 402
296 HYPERLIPIDAEMIA 398
297 FEBRILE NEUTROPENIA 395
298 LUNG DISORDER 395
299 PHARMACEUTICAL PRODUCT COMPLAINT 395
300 VISUAL ACUITY REDUCED 395
301 HYPOMAGNESAEMIA 394
302 PULMONARY FIBROSIS 394
303 ABASIA 387
304 BREAST CANCER 387
305 CONTRAINDICATED PRODUCT ADMINISTERED 385
306 DYSSTASIA 382
307 ERECTILE DYSFUNCTION 381
308 HAEMORRHOIDS 381
309 CARDIOMEGALY 380
310 CEREBRAL HAEMORRHAGE 380
311 ELECTROCARDIOGRAM QT PROLONGED 380
312 HIP FRACTURE 380
313 MENTAL STATUS CHANGES 380
314 BLOOD SODIUM DECREASED 374
315 DISCOMFORT 374
316 CYSTITIS 373
317 DIVERTICULITIS 373
318 INTERVERTEBRAL DISC PROTRUSION 373
319 ANAPHYLACTIC REACTION 371
320 SLEEP APNOEA SYNDROME 371
321 COORDINATION ABNORMAL 370
322 ULCER 369
323 INJECTION SITE BRUISING 368
324 HAEMATOMA 367
325 DRUG WITHDRAWAL SYNDROME 366
326 RASH ERYTHEMATOUS 366
327 THERAPEUTIC RESPONSE UNEXPECTED 366
328 DYSKINESIA 363
329 LOWER RESPIRATORY TRACT INFECTION 363
330 UNDERDOSE 363
331 LIMB INJURY 362
332 NIGHTMARE 361
333 ABNORMAL DREAMS 360
334 GASTRIC DISORDER 360
335 PANCREATITIS ACUTE 359
336 TREATMENT FAILURE 358
337 AGGRESSION 357
338 ILL-DEFINED DISORDER 357
339 STAPHYLOCOCCAL INFECTION 356
340 DELIRIUM 355
341 INJECTION SITE PRURITUS 355
342 MULTI-ORGAN FAILURE 355
343 LIP SWELLING 354
344 HEPATITIS 352
345 FEELING COLD 351
346 CIRCULATORY COLLAPSE 348
347 OCULAR HYPERAEMIA 348
348 URINARY RETENTION 346
349 HAEMATEMESIS 343
350 FIBROMYALGIA 341
351 GOUT 340
352 THERAPEUTIC PRODUCT EFFECT DECREASED 340
353 UNRESPONSIVE TO STIMULI 339
354 FAECES DISCOLOURED 338
355 BONE DISORDER 337
356 HIATUS HERNIA 336
357 RED BLOOD CELL SEDIMENTATION RATE INCREASED 336
358 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 335
359 DIABETES MELLITUS INADEQUATE CONTROL 334
360 NO ADVERSE EVENT 334
361 COLITIS 332
362 ORAL PAIN 332
363 JAUNDICE 331
364 MYOCARDIAL ISCHAEMIA 331
365 PANIC ATTACK 331
366 SURGERY 331
367 BLOOD POTASSIUM INCREASED 328
368 PRODUCT DOSE OMISSION 328
369 RASH MACULAR 328
370 BASAL CELL CARCINOMA 327
371 JOINT STIFFNESS 327
372 SKIN DISORDER 327
373 BLINDNESS 325
374 PSORIATIC ARTHROPATHY 323
375 HYPERSOMNIA 322
376 BODY HEIGHT DECREASED 321
377 FUNGAL INFECTION 319
378 LEUKOPENIA 318
379 MITRAL VALVE INCOMPETENCE 318
380 PAIN IN JAW 318
381 GASTRIC ULCER 316
382 ACTIVITIES OF DAILY LIVING IMPAIRED 315
383 APHASIA 315
384 MOVEMENT DISORDER 315
385 HYPOACUSIS 314
386 NEPHROGENIC ANAEMIA 314
387 PRURITUS GENERALISED 312
388 DISEASE RECURRENCE 311
389 HYPOCALCAEMIA 310
390 MENTAL DISORDER 310
391 AGEUSIA 309
392 EYE DISORDER 308
393 EYE SWELLING 308
394 DEAFNESS 307
395 BLOOD PRESSURE ABNORMAL 304
396 HYPOPHAGIA 304
397 NIGHT SWEATS 304
398 PULMONARY HYPERTENSION 304
399 MULTIPLE SCLEROSIS 301
400 PALLOR 300
401 LYMPHADENOPATHY 299
402 RENAL FAILURE CHRONIC 297
403 DIPLOPIA 296
404 LACRIMATION INCREASED 296
405 GLYCOSYLATED HAEMOGLOBIN INCREASED 295
406 HAEMOPTYSIS 295
407 RESPIRATORY ARREST 295
408 ABNORMAL BEHAVIOUR 294
409 HYPERTENSIVE CRISIS 294
410 INTESTINAL OBSTRUCTION 294
411 CARDIOGENIC SHOCK 293
412 ECONOMIC PROBLEM 293
413 CHROMATURIA 292
414 SKIN BURNING SENSATION 292
415 INJECTION SITE REACTION 291
416 CRYING 289
417 DRUG-INDUCED LIVER INJURY 289
418 RESPIRATORY DISTRESS 289
419 ANGINA UNSTABLE 288
420 LOCAL SWELLING 288
421 BLOOD BILIRUBIN INCREASED 287
422 HALLUCINATION, VISUAL 287
423 RETCHING 287
424 ANOREXIA 286
425 LOCALISED INFECTION 286
426 THERAPY CESSATION 286
427 BLOOD URINE PRESENT 282
428 PSYCHOTIC DISORDER 281
429 UPPER GASTROINTESTINAL HAEMORRHAGE 281
430 INJECTION SITE SWELLING 280
431 RASH GENERALISED 279
432 RESTLESSNESS 279
433 TUBULOINTERSTITIAL NEPHRITIS 279
434 BLOOD PRESSURE INADEQUATELY CONTROLLED 278
435 NEOPLASM MALIGNANT 278
436 ASCITES 276
437 SKIN LESION 273
438 VIRAL INFECTION 272
439 MIDDLE INSOMNIA 270
440 DRUG ADMINISTRATION ERROR 267
441 MUSCULOSKELETAL DISCOMFORT 266
442 WITHDRAWAL SYNDROME 266
443 EATING DISORDER 265
444 MULTIPLE SCLEROSIS RELAPSE 265
445 SCIATICA 265
446 ARTERIOSCLEROSIS 264
447 GLAUCOMA 263
448 WOUND 262
449 LEUKOCYTOSIS 261
450 VENTRICULAR TACHYCARDIA 259
451 EMOTIONAL DISORDER 257
452 THROAT TIGHTNESS 257
453 BLOOD PRESSURE DIASTOLIC DECREASED 256
454 CEREBRAL INFARCTION 256
455 RIB FRACTURE 256
456 NOCTURIA 255
457 ACCIDENTAL OVERDOSE 254
458 SPINAL OSTEOARTHRITIS 254
459 VENTRICULAR EXTRASYSTOLES 253
460 DEMENTIA 252
461 THERAPY INTERRUPTED 252
462 DEVICE MALFUNCTION 250
463 NEURALGIA 250
464 COAGULOPATHY 249
465 IRRITABLE BOWEL SYNDROME 249
466 JOINT INJURY 249
467 NERVOUS SYSTEM DISORDER 248
468 COLD SWEAT 246
469 PERICARDIAL EFFUSION 246
470 TOOTH DISORDER 246
471 DRUG EFFECT INCOMPLETE 245
472 FEELING JITTERY 244
473 GALLBLADDER DISORDER 244
474 INCORRECT DRUG ADMINISTRATION DURATION 244
475 PERIPHERAL COLDNESS 244
476 THERAPY NON-RESPONDER 243
477 JOINT RANGE OF MOTION DECREASED 241
478 THYROID DISORDER 241
479 GAIT INABILITY 240
480 HAIR COLOUR CHANGES 240
481 HAIR TEXTURE ABNORMAL 240
482 POST PROCEDURAL COMPLICATION 240
483 MUSCLE TWITCHING 239
484 RESTLESS LEGS SYNDROME 239
485 OBESITY 238
486 CARPAL TUNNEL SYNDROME 237
487 INTENTIONAL DRUG MISUSE 237
488 DIABETIC NEUROPATHY 236
489 HYPERCALCAEMIA 236
490 LUNG NEOPLASM MALIGNANT 236
491 GLOSSODYNIA 235
492 INTERVERTEBRAL DISC DEGENERATION 235
493 ISCHAEMIC STROKE 235
494 RESPIRATORY DISORDER 235
495 PNEUMONIA ASPIRATION 234
496 SINUS DISORDER 234
497 OSTEOPENIA 233
498 ECZEMA 232
499 ROTATOR CUFF SYNDROME 232
500 BURSITIS 231
501 DIVERTICULUM 231
502 FULL BLOOD COUNT DECREASED 231
503 LABORATORY TEST ABNORMAL 230
504 RENAL CYST 230
505 DRUG DEPENDENCE 229
506 OSTEOMYELITIS 229
507 GAMMA-GLUTAMYLTRANSFERASE INCREASED 227
508 CARDIOVASCULAR DISORDER 226
509 PROTEINURIA 224
510 VITAMIN D DEFICIENCY 222
511 EXOSTOSIS 221
512 PNEUMONITIS 221
513 ABDOMINAL PAIN LOWER 220
514 ACUTE RESPIRATORY FAILURE 220
515 ENCEPHALOPATHY 217
516 FOOT FRACTURE 217
517 PSYCHOLOGICAL TRAUMA 217
518 SEDATION 217
519 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 217
520 DRUG ABUSE 216
521 ANURIA 215
522 HEPATIC FAILURE 215
523 ATRIOVENTRICULAR BLOCK FIRST DEGREE 214
524 EYE PRURITUS 214
525 ADRENAL INSUFFICIENCY 211
526 DRUG TOXICITY 211
527 SUBDURAL HAEMATOMA 211
528 TEMPERATURE INTOLERANCE 211
529 ACUTE RESPIRATORY DISTRESS SYNDROME 210
530 DEVICE ISSUE 210
531 ACNE 209
532 BREAST CANCER FEMALE 209
533 CROHN^S DISEASE 209
534 INJECTION SITE MASS 208
535 MENTAL IMPAIRMENT 208
536 NEPHROPATHY 208
537 NEUTROPHIL COUNT DECREASED 208
538 ANGER 207
539 ARTERIAL OCCLUSIVE DISEASE 207
540 ERUCTATION 207
541 ATRIOVENTRICULAR BLOCK COMPLETE 205
542 EAR PAIN 205
543 SPINAL FRACTURE 205
544 DRUG ERUPTION 204
545 NEOPLASM PROGRESSION 204
546 FREQUENT BOWEL MOVEMENTS 203
547 PLASMA CELL MYELOMA 203
548 TOOTHACHE 203
549 BACK DISORDER 202
550 OSTEONECROSIS OF JAW 202
551 RASH MACULO-PAPULAR 202
552 SKIN CANCER 202
553 HEAD DISCOMFORT 201
554 OSTEONECROSIS 201
555 SCAR 201
556 SINUS CONGESTION 201
557 ATELECTASIS 200
558 HELICOBACTER INFECTION 200
559 MASS 199
560 HEMIPARESIS 198
561 THINKING ABNORMAL 198
562 UPPER LIMB FRACTURE 198
563 ACUTE CORONARY SYNDROME 197
564 ATRIOVENTRICULAR BLOCK 197
565 OESOPHAGITIS 197
566 CHOLESTASIS 196
567 VENTRICULAR FIBRILLATION 196
568 RENAL TUBULAR NECROSIS 195
569 KIDNEY INFECTION 194
570 PHARYNGEAL OEDEMA 194
571 POOR QUALITY SLEEP 194
572 VAGINAL HAEMORRHAGE 194
573 EXTRAPYRAMIDAL DISORDER 193
574 HALLUCINATION, AUDITORY 193
575 PULMONARY CONGESTION 193
576 ANKLE FRACTURE 192
577 PRESCRIBED UNDERDOSE 192
578 ARTERIOSCLEROSIS CORONARY ARTERY 191
579 CHOKING 191
580 SPINAL DISORDER 191
581 TENDERNESS 190
582 DERMATITIS 189
583 EAR INFECTION 189
584 JOINT DISLOCATION 189
585 RESPIRATORY TRACT INFECTION 189
586 IMMUNODEFICIENCY 188
587 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 188
588 PROSTATE CANCER 188
589 THIRST 187
590 BLOOD TEST ABNORMAL 186
591 CYANOSIS 186
592 DISABILITY 186
593 MADAROSIS 186
594 SENSORY DISTURBANCE 186
595 BONE DENSITY DECREASED 185
596 FLUID OVERLOAD 185
597 HAIR DISORDER 185
598 SNEEZING 185
599 SUPRAVENTRICULAR TACHYCARDIA 185
600 PHOTOPHOBIA 184
601 TRICUSPID VALVE INCOMPETENCE 184
602 PARAESTHESIA ORAL 182
603 AORTIC ANEURYSM 181
604 GINGIVAL BLEEDING 181
605 HAEMODIALYSIS 180
606 CARDIOMYOPATHY 179
607 HYPERPARATHYROIDISM SECONDARY 179
608 HERNIA 178
609 POST-TRAUMATIC STRESS DISORDER 178
610 ATRIAL FLUTTER 177
611 HEPATIC FUNCTION ABNORMAL 177
612 KNEE ARTHROPLASTY 177
613 MOUTH ULCERATION 177
614 MUSCULOSKELETAL CHEST PAIN 177
615 BODY TEMPERATURE INCREASED 176
616 PROSTATIC SPECIFIC ANTIGEN INCREASED 176
617 STEVENS-JOHNSON SYNDROME 176
618 HYPOKINESIA 175
619 BLOOD GLUCOSE ABNORMAL 174
620 CORONARY ARTERY STENOSIS 174
621 DENTAL CARIES 174
622 IRON DEFICIENCY ANAEMIA 174
623 MUSCLE TIGHTNESS 174
624 DRUG LEVEL INCREASED 173
625 EYE HAEMORRHAGE 173
626 GENERALISED OEDEMA 173
627 HYPERCHOLESTEROLAEMIA 173
628 MUSCLE ATROPHY 173
629 POISONING 173
630 PULMONARY MASS 173
631 RASH PAPULAR 173
632 MUCOSAL INFLAMMATION 172
633 PURPURA 172
634 FEEDING DISORDER 171
635 TENDONITIS 171
636 TRANSAMINASES INCREASED 171
637 CARDIAC MURMUR 170
638 ORAL DISCOMFORT 170
639 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 170
640 GASTROENTERITIS 169
641 MOOD ALTERED 169
642 DYSLIPIDAEMIA 168
643 EXPIRED PRODUCT ADMINISTERED 168
644 EXTRASYSTOLES 168
645 BACTERIAL INFECTION 167
646 COLITIS ULCERATIVE 167
647 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 167
648 INCREASED APPETITE 167
649 INITIAL INSOMNIA 167
650 ANAPHYLACTIC SHOCK 166
651 PETECHIAE 166
652 RESPIRATORY DEPRESSION 166
653 LOWER LIMB FRACTURE 165
654 MOOD SWINGS 165
655 PARANOIA 165
656 SINUS TACHYCARDIA 165
657 HEPATIC CIRRHOSIS 164
658 DUODENAL ULCER 163
659 MACULAR DEGENERATION 163
660 AGRANULOCYTOSIS 162
661 GASTROENTERITIS VIRAL 162
662 BLADDER DISORDER 161
663 DIABETIC KETOACIDOSIS 160
664 ELECTROLYTE IMBALANCE 160
665 SMALL INTESTINAL OBSTRUCTION 160
666 BREATH SOUNDS ABNORMAL 159
667 TOOTH INFECTION 159
668 BLINDNESS UNILATERAL 158
669 DEMYELINATION 158
670 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 158
671 BONE MARROW FAILURE 157
672 EJECTION FRACTION DECREASED 157
673 HYPOVOLAEMIA 157
674 MULTIPLE FRACTURES 157
675 PHOTOSENSITIVITY REACTION 156
676 LEFT VENTRICULAR HYPERTROPHY 155
677 PROCEDURAL PAIN 155
678 BLOOD MAGNESIUM DECREASED 154
679 ELECTROCARDIOGRAM ABNORMAL 154
680 INCREASED TENDENCY TO BRUISE 154
681 NEUTROPHIL COUNT INCREASED 154
682 BRONCHOSPASM 153
683 DIALYSIS 153
684 FOOT DEFORMITY 153
685 VISUAL DISTURBANCE 153
686 CLOSTRIDIUM DIFFICILE INFECTION 152
687 HYPOAESTHESIA ORAL 152
688 PERIPHERAL VASCULAR DISORDER 152
689 TARDIVE DYSKINESIA 152
690 GLOMERULAR FILTRATION RATE DECREASED 151
691 IMPAIRED WORK ABILITY 151
692 TOOTH FRACTURE 151
693 BEDRIDDEN 150
694 PROTHROMBIN TIME PROLONGED 150
695 BACK INJURY 149
696 INCONTINENCE 149
697 PHARYNGITIS 149
698 SEROTONIN SYNDROME 149
699 ACCIDENTAL EXPOSURE TO PRODUCT 148
700 CORONARY ARTERIAL STENT INSERTION 148
701 HYPERTHYROIDISM 148
702 RHINITIS 148
703 NEEDLE ISSUE 147
704 SPINAL COLUMN STENOSIS 147
705 STOMACH DISCOMFORT 147
706 SYSTEMIC LUPUS ERYTHEMATOSUS 147
707 HYPOTHERMIA 146
708 LACERATION 146
709 MATERNAL EXPOSURE DURING PREGNANCY 146
710 RESPIRATORY TRACT CONGESTION 146
711 BLOOD URIC ACID INCREASED 145
712 EOSINOPHILIA 145
713 INFARCTION 145
714 CHOLECYSTITIS 144
715 MYOSITIS 144
716 SEASONAL ALLERGY 144
717 FLANK PAIN 143
718 MICTURITION URGENCY 143
719 PARALYSIS 143
720 RHEUMATOID FACTOR POSITIVE 143
721 SKIN NECROSIS 143
722 VASCULITIS 143
723 INTENTIONAL DOSE OMISSION 142
724 PLATELET COUNT INCREASED 142
725 SKIN LACERATION 142
726 UROSEPSIS 141
727 VITAMIN D DECREASED 141
728 BLOOD COUNT ABNORMAL 140
729 NODULE 140
730 BLOOD CALCIUM DECREASED 139
731 MYOPATHY 139
732 WRIST FRACTURE 139
733 APPLICATION SITE ERYTHEMA 138
734 BODY TEMPERATURE DECREASED 138
735 LIPASE INCREASED 138
736 POLYURIA 138
737 URINE OUTPUT DECREASED 138
738 HAEMORRHAGIC STROKE 137
739 IMPAIRED GASTRIC EMPTYING 137
740 LIVER INJURY 137
741 REBOUND ACID HYPERSECRETION 137
742 STENT PLACEMENT 137
743 CYST 136
744 EXTRA DOSE ADMINISTERED 136
745 HAEMORRHAGE INTRACRANIAL 136
746 MUSCULOSKELETAL DISORDER 136
747 NERVE COMPRESSION 136
748 SOPOR 136
749 SQUAMOUS CELL CARCINOMA 136
750 CLOSTRIDIUM DIFFICILE COLITIS 135
751 ECCHYMOSIS 135
752 EMPHYSEMA 135
753 POLYP 135
754 HEPATOTOXICITY 134
755 LOW DENSITY LIPOPROTEIN INCREASED 134
756 VITREOUS FLOATERS 134
757 GRAND MAL CONVULSION 133
758 INTERVERTEBRAL DISCITIS 133
759 LUNG INFILTRATION 133
760 SKIN IRRITATION 133
761 ATAXIA 132
762 BLOOD IRON DECREASED 132
763 HAEMORRHAGIC ANAEMIA 132
764 INJECTION SITE RASH 132
765 HIP ARTHROPLASTY 131
766 HYPOPHOSPHATAEMIA 131
767 OBSTRUCTIVE AIRWAYS DISORDER 131
768 RALES 131
769 SLUGGISHNESS 131
770 BLOOD ALBUMIN DECREASED 130
771 C-REACTIVE PROTEIN ABNORMAL 130
772 IMPAIRED QUALITY OF LIFE 130
773 LUNG INFECTION 130
774 ORAL CANDIDIASIS 130
775 PAIN OF SKIN 130
776 APPLICATION SITE PRURITUS 129
777 BLOOD GLUCOSE FLUCTUATION 129
778 TOOTH ABSCESS 129
779 CANDIDA INFECTION 128
780 EPILEPSY 128
781 LYMPHOCYTE COUNT DECREASED 128
782 MYOCLONUS 128
783 POSTOPERATIVE WOUND INFECTION 128
784 TASTE DISORDER 128
785 URINE ODOUR ABNORMAL 128
786 CAROTID ARTERY STENOSIS 127
787 INTERNATIONAL NORMALISED RATIO DECREASED 127
788 LOWER GASTROINTESTINAL HAEMORRHAGE 127
789 VITAMIN B12 DEFICIENCY 127
790 COLON CANCER 126
791 ORAL HERPES 126
792 DIFFICULTY IN WALKING 125
793 DIZZINESS POSTURAL 125
794 DRUG PRESCRIBING ERROR 125
795 PRESCRIBED OVERDOSE 125
796 RENAL PAIN 125
797 BLOOD LACTATE DEHYDROGENASE INCREASED 124
798 CORONARY ARTERY BYPASS 124
799 ELECTRIC SHOCK 124
800 GROIN PAIN 124
801 TENDON RUPTURE 124
802 ACIDOSIS 123
803 FURUNCLE 123
804 PULMONARY THROMBOSIS 123
805 SPLENOMEGALY 123
806 THERAPEUTIC RESPONSE SHORTENED 123
807 TOOTH LOSS 123
808 CONCUSSION 122
809 DELUSION 122
810 DRUG DISPENSING ERROR 122
811 METASTASES TO BONE 122
812 ALTERED STATE OF CONSCIOUSNESS 121
813 DRUG EXPOSURE DURING PREGNANCY 121
814 RHEUMATOID NODULE 121
815 DECREASED ACTIVITY 120
816 IMPAIRED DRIVING ABILITY 120
817 PRODUCT PHYSICAL ISSUE 120
818 BLOOD CHOLESTEROL ABNORMAL 119
819 INJECTION SITE NODULE 119
820 SKIN HAEMORRHAGE 119
821 ABSCESS 118
822 APHONIA 118
823 BUNDLE BRANCH BLOCK RIGHT 118
824 LYMPHOMA 118
825 RESPIRATORY RATE INCREASED 118
826 SKIN FISSURES 118
827 TOOTH EXTRACTION 118
828 UPPER-AIRWAY COUGH SYNDROME 118
829 ANOSMIA 117
830 CARDIAC VALVE DISEASE 117
831 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 117
832 SPINAL PAIN 117
833 INTRAOCULAR PRESSURE INCREASED 116
834 MALNUTRITION 116
835 PRODUCT ADHESION ISSUE 116
836 CAROTID ARTERY OCCLUSION 115
837 MUSCLE RIGIDITY 115
838 PANNICULITIS 115
839 RASH PUSTULAR 115
840 SUDDEN DEATH 115
841 EYELID OEDEMA 114
842 HEPATOCELLULAR INJURY 114
843 MUSCLE DISORDER 114
844 NO THERAPEUTIC RESPONSE 114
845 BUNDLE BRANCH BLOCK LEFT 113
846 FACE OEDEMA 113
847 GINGIVAL PAIN 113
848 HIGH DENSITY LIPOPROTEIN DECREASED 113
849 OVERWEIGHT 113
850 PROCTALGIA 113
851 BLOOD PARATHYROID HORMONE DECREASED 112
852 GLUCOSE TOLERANCE IMPAIRED 112
853 METASTASES TO LIVER 112
854 BENIGN PROSTATIC HYPERPLASIA 111
855 GRANULOMA SKIN 111
856 PELVIC PAIN 111
857 SCOLIOSIS 111
858 BLOOD CALCIUM INCREASED 110
859 ESSENTIAL HYPERTENSION 110
860 NERVE INJURY 110
861 PHARYNGOLARYNGEAL PAIN 110
862 PRODUCT PRESCRIBING ERROR 110
863 PULSE ABSENT 110
864 DEVICE RELATED INFECTION 109
865 FOETAL EXPOSURE DURING PREGNANCY 109
866 MALIGNANT MELANOMA 109
867 MANIA 109
868 PRODUCT TASTE ABNORMAL 109
869 SCAB 109
870 SUBARACHNOID HAEMORRHAGE 109
871 ASPIRATION 108
872 BLOOD PRESSURE SYSTOLIC DECREASED 108
873 BLOOD THYROID STIMULATING HORMONE INCREASED 108
874 CARDIAC FLUTTER 108
875 BREAST MASS 107
876 HEPATOMEGALY 107
877 BIPOLAR DISORDER 106
878 BLADDER CANCER 106
879 DRY THROAT 106
880 GASTROINTESTINAL PAIN 106
881 VENTRICULAR HYPERTROPHY 106
882 FIBROSIS 105
883 LIGAMENT SPRAIN 105
884 MULTIPLE ORGAN DYSFUNCTION SYNDROME 105
885 MUSCLE STRAIN 105
886 RHINITIS ALLERGIC 105
887 EYE INFECTION 104
888 GASTRIC ULCER HAEMORRHAGE 104
889 MOTOR DYSFUNCTION 104
890 SPINAL COMPRESSION FRACTURE 104
891 BREAST PAIN 103
892 CEREBRAL ISCHAEMIA 103
893 FRACTURE 103
894 HAEMODYNAMIC INSTABILITY 103
895 HEPATITIS ACUTE 103
896 INJECTION SITE HAEMATOMA 103
897 INJECTION SITE URTICARIA 103
898 LIBIDO DECREASED 103
899 MIOSIS 103
900 PARKINSON^S DISEASE 103
901 PRODUCT STORAGE ERROR 103
902 THERAPEUTIC AGENT TOXICITY 103
903 CATARACT OPERATION 102
904 CHOLECYSTITIS ACUTE 102
905 SUPRAVENTRICULAR EXTRASYSTOLES 102
906 DISSEMINATED INTRAVASCULAR COAGULATION 101
907 HEARING IMPAIRED 101
908 HEMIPLEGIA 101
909 LYMPHOEDEMA 101
910 MULTIPLE DRUG OVERDOSE 101
911 POTENTIATING DRUG INTERACTION 101
912 TORSADE DE POINTES 101
913 AZOTAEMIA 100
914 CHOLECYSTECTOMY 100
915 ILEUS 100
916 SHOCK HAEMORRHAGIC 100
917 HYPERKERATOSIS 99
918 INJECTION SITE EXTRAVASATION 99
919 INTESTINAL ISCHAEMIA 99
920 PERITONITIS 99
921 PRODUCT AVAILABILITY ISSUE 99
922 TONGUE DISORDER 99
923 EXPOSURE DURING PREGNANCY 98
924 ISCHAEMIC CARDIOMYOPATHY 98
925 LIVER FUNCTION TEST INCREASED 98
926 NEOPLASM 98
927 PANCREATIC CARCINOMA 98
928 PEMPHIGOID 98
929 SENSORY LOSS 98
930 TROPONIN INCREASED 98
931 ACUTE PULMONARY OEDEMA 97
932 ANGIONEUROTIC OEDEMA 97
933 AORTIC VALVE INCOMPETENCE 97
934 LOSS OF EMPLOYMENT 97
935 PRE-EXISTING CONDITION IMPROVED 97
936 SEXUAL DYSFUNCTION 97
937 FINGER DEFORMITY 96
938 FRUSTRATION TOLERANCE DECREASED 96
939 GYNAECOMASTIA 96
940 POST PROCEDURAL HAEMORRHAGE 96
941 REFUSAL OF TREATMENT BY PATIENT 96
942 BACTERAEMIA 95
943 GASTRIC HAEMORRHAGE 95
944 LARYNGITIS 95
945 MAJOR DEPRESSION 95
946 NAIL DISORDER 95
947 PRODUCT DOSE OMISSION IN ERROR 95
948 CONJUNCTIVITIS 94
949 ISCHAEMIA 94
950 NEPHROGENIC SYSTEMIC FIBROSIS 94
951 ONYCHOCLASIS 94
952 PREMATURE BABY 94
953 BLOOD CHLORIDE DECREASED 93
954 EYELID PTOSIS 93
955 GUILLAIN-BARRE SYNDROME 93
956 IMMUNE SYSTEM DISORDER 93
957 INCOHERENT 93
958 LEFT VENTRICULAR DYSFUNCTION 93
959 MULTIPLE INJURIES 93
960 NASAL DISCOMFORT 93
961 SALIVARY HYPERSECRETION 93
962 WOUND INFECTION 93
963 ACCIDENT 92
964 APATHY 92
965 APPLICATION SITE PAIN 92
966 CEREBRAL HAEMATOMA 92
967 DIVERTICULUM INTESTINAL 92
968 DRUG TOLERANCE DECREASED 92
969 GINGIVITIS 92
970 PYELONEPHRITIS 92
971 SKIN INFECTION 92
972 TOXIC SKIN ERUPTION 92
973 TRANSFUSION 92
974 COLITIS ISCHAEMIC 91
975 DIARRHOEA HAEMORRHAGIC 91
976 FACIAL PAIN 91
977 GENERALISED TONIC-CLONIC SEIZURE 91
978 HYPERAESTHESIA 91
979 PRODUCT ADMINISTRATION ERROR 91
980 PSYCHOMOTOR HYPERACTIVITY 91
981 SQUAMOUS CELL CARCINOMA OF SKIN 91
982 TACHYPNOEA 91
983 WALKING AID USER 91
984 BLOOD PRESSURE SYSTOLIC ABNORMAL 90
985 CEREBRAL ATROPHY 90
986 DECUBITUS ULCER 90
987 INGUINAL HERNIA 90
988 MONOCYTE COUNT INCREASED 90
989 TOXIC EPIDERMAL NECROLYSIS 90
990 EAR DISCOMFORT 89
991 NASAL DRYNESS 89
992 ORTHOPNOEA 89
993 QUALITY OF LIFE DECREASED 89
994 ATRIOVENTRICULAR BLOCK SECOND DEGREE 88
995 CANDIDIASIS 88
996 CYTOLYTIC HEPATITIS 88
997 FISTULA 88
998 HAEMORRHOIDAL HAEMORRHAGE 88
999 INJECTION SITE WARMTH 88